Back to News
Market Impact: 0.15
Cybin Inc. Announces Co-Founders Eric So and Paul Glavine Transition from Executive Roles
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Cybin Inc., now operating as Helus Pharma Inc., said co-founders Eric So and Paul Glavine stepped down from their respective executive and consulting roles, effective October 26, 2026. The provided article text gives no reason for the departures or further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
HELP-0.40
More News
- Paraguay’s Santiago Pena under arrest, new president Pedro Alliana sworn in
- Fox wraps up its $22 billion Roku deal
- Apollo-backed dental firm vVardis seeks up to $229 million in US IPO
- Trump Names Miller Chief of Staff as Tech Rebounds
- How Paraguay’s Ueno collapse is only its latest banking crisis
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction